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1. Introduction  
The concept of neurocristopathy was introduced by Bolande in 1974 to describe a group of 
diseases arising from aberrations in the development, migration and differentiation of the 
embryonic neural crest (NC). This cell lineage differentiates into pigmentary and neural cells 
and forms part of the autonomous nervous system, nervous enteric plexus, as well as 
endocrine glands (adrenals, parathyroid gland) and chemoreceptors (carotid and aortic 
bodies). Neurocristopathies derived from a failure in NC development and range from 
alterations in intestinal ganglion cells, as seen in Hirschsprung’s Disease or in intestinal 
neuronal dysplasia, to alterations in skin pigmentation (such as neurofibromatosis, 
Waardenburg-Shah syndrome and piebaldism) (Spritz, 1997). In recent years, fostered by 
the increasing research on the NC ontogeny (Trainor, 2005), the notion of cristopathies has 
widened (Bolande, 1997), particularly with the inclusion of craniofacial syndromes of cranial 
crest mesoectodermal origin, often accompanied by morphological brain abnormalities 
(Couly & Aicardi, 1988), as well as the association with other diseases (Martucciello et al., 
2005), including chromosomopathies (Down syndrome), embryopathies (fetal alcohol and 
fetal cocaine syndromes) and tumors of the endocrine system (multiple endocrine neoplasia 
type IIB).  
Based on the accumulating knowledge of the role of NC in development, Jones (1990) 
proposed a new classification of cristopathies according to the pathological mechanism 
involved. The first group includes the defects and disorders originally defined as 
neurocristopathies including pheochromocytoma, neurofibromatosis, and the multiple 
endocrine adenomatoses. These diseases can be explained as dysplasia of neural crest 
derivatives. Affected individuals rarely exhibit actual morphological malformations but do 
carry a risk for impaired growth of crest-derived tissue. The second group corresponds to 
defects and disorders which derive from migrational abnormalities primarily of cranial NC 
cells such as frontonasal dysplasia, the DiGeorge sequence, velo-cardio-facial syndrome and 
Waardenberg syndrome represent true malformations. The genetic origins of some of these 
syndromes have been identified: microdeletions at the locus 22q11.2 (DiGeorge sequence 
and velo-cardio-facial syndromes) and mutations in the PAX3, MITF, EDNRB, EDN3 and 
SOX10 genes (Waardenberg syndrome I-IV types) 
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Hirschsprung’s disease (HSCR) or aganglionic megacolon is perhaps the best-studied 
neurocristopathy. HSCR is a congenital defect characterized by complete absence of 
intramural neuronal ganglion cells in the myenteric (Auerbach's) plexus and the submucosal 
(Meissner's) plexus from distal portions of the intestinal tract caused by failure in the 
migration of these cells from the NC. HSCR is a disorder with multifactorial etiology 
including genetic factors (Kusafuka & Puri, 1998). Mutations in at least 8 genes have been 
associated with HSCR, most of the mutations occurring in the RET gene. According to 
epidemiology studies (Amiel & Lyonnet, 2001; Luis et al., 2006; Polly & Coran, 1993), HSCR 
appears as an isolated trait in 70% of cases. HSCR is associated with a chromosomal 
abnormality in 12% of cases, of which trisomy 21 (Down syndrome) represents >90%. A 
recent report raises the incidence of Down syndrome up to a 17.6 % of HSCR patients 
(Carrascosa-Romero et al., 2007). Association with other congenital multimalformative 
syndromes and isolated dysmorphic conditions anomalies are found in up to 18% of HSCR 
patients. The ones occurring at a frequency above that expected by chance include 
gastrointestinal malformation, cleft palate, polydactyly, cardiac septal defects, and 
craniofacial anomalies. HSCR has also been connected with nervous system malformations 
related to alterations in the development of the anterior segment of the NC: defects in the 
closure of the neural tube such as anencephalia and myelomeningocele, as well as 
impairment of neuronal migration and brain dysgenesis (Carrascosa-Romero et al., 2007; 
Juliá et al., 2003; Shahar & Shinawi, 2003). 
2. Evidence that glial cell are critical participants in every major aspect of 
brain development, function, and disease 
Astrocytes are the most abundant cell type in the mammalian brain. Interest in astrocyte 
function has increased dramatically in recent years because of their newly discovered roles 
in synapse formation, maturation, efficacy, and plasticity. However, our understanding of 
astrocyte development has lagged behind that of other brain cell types. We do not know the 
molecular mechanism by which astrocytes are specified, how they grow to assume their 
complex morphologies, and how they interact with and sculpt developing neuronal circuits. 
Recent work has provided a basic understanding of how intrinsic and extrinsic mechanisms 
govern the production of astrocytes from precursor cells and the generation of astrocyte 
diversity. Moreover, new studies of astrocyte morphology have revealed that mature 
astrocytes are extraordinarily complex, interact with many thousands of synapses, and tile 
with other astrocytes to occupy unique spatial domains in the brain. A major challenge for 
the field is to understand how astrocytes talk to each other, and to neurons, during 
development to establish appropriate astrocytic and neuronal network architectures 
(Freeman, 2010). Astrocytes influence synaptic transmission in many ways. They secrete 
distinct factors that promote synaptogenesis, neurotransmitter release, and postsynaptic 
receptors (Barres, 2008); in addition, they release so-called gliotransmitters in response to 
stimulation and contribute to the calcium waves that correlate with blood flow (Haydon & 
Carmignoto, 2006; Volterra A & Meldolesi, 2005). However, they also participate directly in 
synaptic transmission through the expression of high-affinity transporters for 
neurotransmitters.  
Emerging evidence indicates that signalling between perisynaptic astrocytes and neurons at 
the tripartite synapse plays an important role during the critical period when neural circuits 
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are formed and refined. Cross-talk between astrocytes and neurons during development 
mediates synaptogenesis, synapse elimination and structural plasticity through a variety of 
secreted and contact-dependent signals. Recent live imaging studies reveal a dynamic and 
cooperative interplay between astrocytes and neurons at synapses that is guided by a 
variety of molecular cues. A unifying theme from these recent findings is that astrocytes can 
promote the development and plasticity of synaptic circuits. Insight into the molecular 
mechanisms by which astrocytes regulate the wiring of the brain during development could 
lead to new therapeutic strategies to promote repair and rewiring of neural circuits in the 
mature brain following central nervous system (CNS) injury and neurodegenerative disease 
(Stevens, 2008).  
3. Neuron-to-glia signalling in the central and enteric nervous system – 
Implications for neural disease 
Dysfunction of non-neuronal cells such as astrocytes and microglia have been involved in 
the process of neurodegeneration in the CNS. In fact, they have been proposed as 
therapeutic targets since their selective survival is capable of slowing down the process of 
neuronal death in animal models of neurodegenerative disease (Boillee et al., 2006; 
Yamanaka et al. 2008). In a healthy individual, astrocytes seem to respond to synaptic 
activity in the CNS in a synapse-specific way and, in turn, they appear to precisely regulate 
synaptic activity. These processes have been shown to involve the activity and expression of 
plasma membrane transporters (Bergles et al., 1999). The excitatory amino acid transporters 
(EAATs) control spillover of glutamate from one synapse to another. Besides this, they also 
prevent accumulation of glutamate at the synapse and subsequent toxicity and they serve to 
recycle the released transmitter for packaging and subsequent release. Most transporters are 
expressed at the nerve terminal, where they are well positioned to serve both functions. 
However, the major EAAT isoforms GLAST (human EAAT1) and GLT1 (human EAAT2) 
are expressed by glia and localize to astrocytic processes that reside at varying distances 
from the synapse. Recent experimental in vivo work has shown that presynaptic terminals 
regulate astroglial GLT1/EAAT2 expression (Yang et al., 2009). The regulation of GLT1 
expression by presynaptic input also raises important questions about cause and effect in 
neural degeneration. It is very clear that loss of GLT1/EAAT2 causes severe toxicity, and 
downregulation may occur in ALS. However, several works (Bergles et al., 1999; Yang et al., 
2009) suggest that the downregulation observed may reflect rather than cause neuronal loss. 
Indeed, downregulation in the absence of neural input might have less deleterious 
consequences than in the intact state, where the release of more glutamate has greater 
potential to produce toxicity. Neuronal regulation presumably serves to coordinate 
glutamate clearance with glutamate release. However, a defect in the signalling mechanism 
might trigger the degenerative process without a primary disorder of the neuron, and even 
secondary changes in EAATs expression may propagate the neuronal injury. 
Glia in the peripheral nervous system also respond to neuronal activity. Enteric glia are 
intimately associated with the neurons from the enteric nervous system (ENS) This 
association is similar in morphology and molecular nature to that shown by neurons and 
glia in the CNS. Astrocyte-like enteroglial cells are actively involved in enteric neuronal 
activity via neurotransmitter receptors. In the ENS, the purine adenosine triphosphate (ATP) 
is released together with noradrenaline and acetylcholine by enteric neurons (Al-Humayyd 
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& White, 1985; Nurgali et al., 2003). ATP plays a pivotal role in regulating synaptic 
transmission in CNS astrocytes (Abbracchio & Ceruti, 2006) and it is involved in controlling 
gastrointestinal motility, secretomotor function, blood flow, and synaptic transmission 
(Bornstein, 2008; Christofi, 2008; Ren & Bertrand, 2008). Enteric glia express purinergic 
receptors and has been reported to respond to ATP in vitro (Gomes et al., 2007; Zhang et al., 
2003) which suggested enteric glia participation in functional gastrointestinal responses to 
nerve signalling. More recently, activation of enteric neurons using electrical field 
stimulation of interganglionic fiber tracts in a longitudinal muscle myenteric plexus 
preparation from Guinea pig colon was able to elicit enteric glial cell activity as assesses by 
intracellular Ca2+ imaging in situ through P2Y4 ATP receptors (Gulbransen & Sharkey, 
2009), providing the first evidence of neuron-to-glia signalling in the ENS. Further to this, 
the same team using a combination of techniques to selectively stimulate or eliminate 
intrinsic and extrinsic populations of neurons found that enteric glia are specifically 
activated by sympathetic postganglionic neurons innervating the colonic myenteric plexus 
(Gulbransen et al., 2010). This result supports the notion that glia are not indiscriminate 
detectors of neuronal activity and can discern activity from specific neural pathways. 
Interestingly, the case of a HSCR patient with a SOX10 gene mutation has recently been 
reported showing neurological impairment entirely due to glial maldevelopment including 
peripheral dysmyelinating neuropathy and enteric neuroglia deficiency (Shimotake et al., 
2007). This discovery has driven renewed interest for neuron-to-glia interactions and 
neuroimaging in the field of neurocristopathies.  
4. Hirschsprung disease (HSCR) or aganglionic megacolon and its 
association with other malformations 
HSCR is a cause of functional intestinal obstruction with an incidence of 1/5000 alive 
newborns (NB) (Lister & Irving, 1990; Amiel & Lyonnet, 2001). However, the incidence has 
been shown to vary significantly among ethnic groups:  1.5, 2.1, and 2.8 per 10 000 live births 
in Caucasians, African-Americans, and Asians, respectively, in the state of California (Amiel 
& Lyonnet, 2001). For comparison, in our Albacete Health Service Area the incidence is 1.6 
per 5000 alive NB (Carrascosa-Romero et al., 2007). Although there are many sporadic cases, 
a heterogeneous familial incidence has also been described involving several genetic factors 
(Amiel & Lyonnet, 2001).  
There is abundant literature connecting HSCR with other malformations (Table 1), 
frequently including cleft palate, iris coloboma and congenital cardiac defects, among others 
(Amiel & Lyonnet, 2001; Scriver et al., 2002). Often, HSCR may appear as part of a well-
known neurocristopathy syndrome such as piebaldism (MIM 172800),  Shah-Waardenburg 
(MIM 277580), congenital central hypoventilation (Haddad, MIM 209880) or Riley-Day 
(MIM 223900) syndromes, or associated to other types of dysmorphic syndromes, such as 
Aarskog (MIM 100050), Rubinstein-Taybi (MIM 180849), or Smith-Lemli-Opitz syndromes 
(MIM 270400), where HSCR is not always present but shows an incidence higher than 
expected by chance. Of interest, Carrascosa-Romero et al., 2007 also reported an unusual 
case of HSCR associated with FG syndrome (MIM 305450), a X-linked heterogeneous genetic 
disorder characterized by hair whorls, broad thumbs and severe constipation (Romano et 
al., 1994), presenting with severe mental retardation. 
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SYNDROMES MIM KEY CLINICAL FEATURES 
 NEUROCRESTOPATHIES  
 
 
 
WS4 (Shah-Waardenburg) 277580 Pigmentary anomalies (white forelock, iris 
hypoplasia, patchy hypopigmentation), deafness. 
Hipopigmentación- Sordera-
Ceguera Yemenite  
601706 Hearing loss, eye anomalies (microcornea, 
coloboma, nystagmus), pigmentary anomalies 
BADS (black locks, 
oculocutaneous albinism, 
sensorineural deafness) 
227010 Hearing loss, hypopigmentation of the skin and 
retina 
Piebaldism 172800 Patchy hypopigmentation of the skin and hair 
Haddad 209880 Congenital central hypoventilation 
MEN2A 171400 Medullary thyroid carcinoma, 
phaeochromocytoma, hyperplasia of the 
parathyroid 
Riley-Day 223900 Autonomic nervous system anomalies 
HSCR MANDATORY   
Goldberg-Shprintzen 609460
235740
Cleft palate, hypotonia, microcephaly, mental 
retardation, dysmorphic facial features 
Hypertelorism, deafness, polydactyly, unilateral 
renal agenesis 
HSCR with limbs anomalies 235750
235760
604211
306980
Postaxial polydactyly, ventricular septal defect 
Hypoplasia of distal phalanges and nails, 
dysmorphic features 
Preaxial polydactyly, heart defect, laryngeal 
anomalies. 
Brachydactyly type D 
BRESHECK  300404 Brain abnormalities, Retardation, Ectodermal 
dysplasia, Skeletal malformation, HSCR, Ear/eye 
anomalies, Cleft palate/Cryptorchidism and 
Kidney dysplasia/hypoplasia 
Mesomelic dysplasia, Werner 
type 
 Mesomelia, polydactyly 
HSCR FREQUENTLY 
ASSOCIATED 
  
Mowat-Wilson 255730 Dysmorphic facial features, microcephaly, mental 
retardation, agenesis of corpus callosum, heart 
disease, urogenital/renal anomalies  
HSCR OCCASIONALLY 
ASSOCIATED 
  
Bardet-Biedl 209900 Pigmentary retinopathy, obesity, hypogenitalism, 
mild mental retardation, postaxial polydactyly 
Kauffman-McKusick 236700 Hydrometrocolpos, postaxial polydactyly, 
congenital heart defect. 
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Smith-Lemli-Opitz 270400 Growth retardation, microcephaly, mental 
retardation, hypospadias, 2–3 toes syndactyly, 
dysmorphic features 
Cartilage-hair hypoplasia 250250 Short limb dwarfism, metaphyseal dysplasia, 
immunodeficiency 
HSCR RARELY ASSOCIATED   
Fukuyama congenital 
muscular dystrophy 
253800 Muscular dystrophy, polymicrogyria, 
hydrocephalus, mental retardation, seizures.  
Clayton-Smith 258840 Dysmorphic features, ichthyosis, hypoplastic toes 
and nails 
Kaplan 304100 Agenesis of corpus callosum, adducted thumbs, 
ptosis, muscle weakness 
Okamoto 308840 Agenesis of corpus callosum, hydrocephalus, cleft 
palate. 
Table 1. Syndromes associated with HSCR (reprinted and adapted from Scriver CM et al, 
eds. “The metabolic and molecular bases of inherited diseases” 8th ed. Chap 251. New York: 
McGraw-Hill: 6231-55.) 
For other syndromes, HSCR is a mandatory feature for diagnosis such as BRESHECK (Brain 
Abnormalities, Retardation, Ectodermal dysplasia, Skeletal malformation, Hirschsprung 
disease, Ear/eye anomalies, Cleft palate/Cryptorchidism and Kidney dysplasia) (MIM 
300404) and the subtypes of HSCR with limb anomalies (MIM 235750, 235760, 604211 and 
306980). HSCR is also a mandatory feature for Goldberg-Shprintzen megacolon syndrome 
(GOSHS MIM 609460)(Goldberg & Shprintzen, 1981). This syndrome is characterized by 
microcephaly, hypertelorism, short stature, cleft palate, learning problems, and seems to be 
caused by homozygous nonsense mutations in  KIAA 1279 located at 10q22.1. GOSHS 
presents various common characteristics with the Mowat-Wilson syndrome (MIM 235730), 
which will be discussed below in section 5. 
HSCR has also been connected with malformations of the nervous system: defects in the 
neural tube closure such as anencephaly (Mathew, 1998) and meningomyelocele (Merkler et 
al., 1985), as well as anomalies in neuronal migration and or cerebral dysgenesis (Cass, 
1990), predominantly agenesis of corpus callosum (Sayed & Al-Alaigan, 1996). These 
phenomena have been regarded as alterations in the embryonic development of the anterior 
portion of the NC (Currie et al., 1986; Hurst et al., 1986). The actual incidence of associated 
brain anomalies has been studied for other neurocristopathies. For example, Couly & 
Aicardi (1983) reported that of a group of 3000 children presenting with facial 
dysembryoplasias, 13 %  also showed brain malformations. Another study showed up to 82 
% (18 out of 25) of children with uni- or bilateral maxillomandibular neurocristopathies 
(Goldenhar's, Franceschetti's first arch syndromes or transient forms) also presented 
morphological and motor anomalies of the brain stem and its corresponding cranial nerves, 
as assessed by neurological and cerebral computed tomography examinations (Couly & Le 
Lievre-Ayer, 1983). However, we have failed to find previous literature studying the 
incidence of brain malformations associated with HSCR. Available reports dealt with 
isolated cases (Turkdogan-Sozuer et al., 1998), sometimes under other denominations such 
as GOSHS. All these cases nonetheless share a common denominator: psychomotor delay, 
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associated to alterations in the CNS, generally:  microcephay, agenesis of corpus callosum, 
white matter atrophy, ventricular dilatation. Few reports describe pachygyria, 
polymicrogyria as well as cerebellar hypoplasia in HSCR patients (Carrascosa-Romero et al., 
2007), perhaps due to the fact that neuroimaging studies are rarely performed on this type of 
patients. Our team did study the incidence of brain malformations associated with HSCR in 
our Albacete Health Service Area. In our study we found 10 cases of isolated HSCR versus 7 
cases of HSCR associated with other structural anomalies or psychomotor retardation, 
which indicated a high incidence of anomalies associated with HSCR (41,1%) in our 
territory. 
4.1 Molecular genetics in HSCR: The RET proto-oncogene 
Segregation studies in nonsyndromic HSCR have shown sibling recurrence risk ranging 
from 1 to 33 %, and it is considered a multifactorial disorder, the effect of genes 
predominating over environmental factors (relative risk of 200). The higher susceptibility for 
HSCR in some families allowed establishing the locus 10q11. 2q21.2 as a genetic origin of the 
disease (Fewtrell et al., 1994.)  The RET proto-oncogen is located in this region and has been 
shown to be highly involved in neurocristopathies (Amiel & Lyonnet, 2001). The RET proto-
oncogen is a tyrosine-protein kinase receptor essential for the glial cell-derived neurotrophic 
factor  (GDNF) actions preventing neuroectodermal cell apoptosis (Mograbi et al., 2001). De 
Pontual et al., 2006, genotyped RET in 143 patients with two syndromic HSCR entities: 
congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by 
PHOX2B and ZFHX1B gene mutations, respectively, finding that there were both RET 
dependent and RET independent HSCR cases. Besides this, RET mutations have been found 
only in 50 % of familial and 15 % to 20 % sporadic HSCR cases (Attie et al., 1995). Therefore, 
notwithstanding the importance of the mutations in the RET gene, there are other genes 
involved in human HSRC: neurturin (NTN), endothelin B receptor (EDNRB), endothelin-3 
(EDN3), endothelin-converting enzyme (ECE1), as well as the SOX10 and SIP1 genes (Amiel 
& Lyonnet, 2001; Mollaaghababa & Pavan, 2003). 
Substance P -a neurotransmitter specific marker of neuronal differentiation- has been found 
downregulated in HSCR suggesting a role for peptidergic innervation in the pathogeny of 
this disease (Tam, 1986). The possible connection between the above mentioned genes, 
substance P and GDNF and the causal mechanism the alteration of neuronal migration in 
the NC morphogenesis is not yet clear, since a high proportion of genetic anomalies cannot 
be identified using a standard screening of genomic DNA. A multiple origin is likely 
including other types of molecular parameters. For example, elevated levels of maternal 
homocysteine have been established as a risk toxicity factor for congenital defects during 
embryonic development, particularly anomalies in the neural tube closure and 
neurocristopathies (Brauer & Tierney, 2004), whereas a prophylactic role has been observed 
for folic acid in both types of pathologies (Antony, 2007). 
5. Mowat-Wilson syndrome 
Mowat-Wilson syndrome (MWS, MIM 235730) is a condition that involves multiple 
congenital defects described by Mowat et al., 1998. They reported a series of six children 
presenting mental retardation, microcephaly, and short stature with a distinctive facial 
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phenotype accompanied by other variable types of congenital anomalies. Five of these 
patients also had HSCR and one presented an interstitial deletion of chromosome 2, del 
(2)(q21q23). These children strongly resembled the patient earlier reported by Lurie et al. 
1994, with HSCR and dysmorphic features also associated with del (2) (q22q23). They 
concluded that these children had a distinct syndrome for which HSCR was not a 
mandatory feature and that could be caused by a contiguous gene syndrome, or a single 
gene disorder, or disruption of a critical region within 2q22-23. In 2001, two independent 
teams (Cacheux et al., 2001; Wakamatsu et al., 2001) identified the cause of MWS as either a 
heterozygous deletion or truncation mutations in the Zinc finger E-box-binding homeobox 2 
gene, ZEB2, (MIM 605802, previously called ZFHX1B) which encodes a smad interacting 
protein 1 (SIP1) located in the above mention chromosome region 2q22-23. 
Since the first description by Mowat et al (1998), approximately 200 patients have been 
reported and over 100 mutations have been described (Dastot-Le Moal et al., 2007). The 
phenotype/genotype correlation for these mutations is very variable, not only for a given 
mutation (Cerruti-Mainardi et al., 2005; Zweier et al., 2003) but also within the same family 
(McGaughran et al., 2005). The syndrome has been identified in several ethnic groups 
(Dastot-Le Moal et al., 2007), with similar clinical features in all populations. The 
male/female ratio is approximately 1,42:1 (Adam et al., 2006; Horn et al., 2004). 
The prevalence of MWS is currently unknown, but it seems probable that the syndrome is 
under-diagnosed, particularly in patients without HSCR (Cerruti-Mainardi et al., 2005). For 
this reason the identification of the facial phenotype is of special relevance for the initial 
clinical diagnosis (Garavelli L & Cerruti-Mainardi, 2007). The clinical features of the face are: 
high forehead, frontal bossing, eyebrows are large, medially flaring and sparse in the middle 
part, hypertelorism with hollow but large eyes, big and uplifted ear lobes with a central 
depression, saddle nose, open mouth, with M-shaped upper lip, frequent smiling and 
occasional drooling (Fig. 1, a and b), and a prominent but narrow and triangular pointed 
chin that further elongates with age ( Fig. 2, a and b).  
At birth, patients show growth parameters with values within normal percentiles but they 
develop microcephaly and short stature progressively with age. The facial phenotype also 
evolves in older children. For example, the eyebrows become thicker, broad and 
horizontal, with an increased wide middle separation and medial sparseness. The nasal 
tip lengthens and becomes more depressed, the columella is more prominent, the nasal 
profile becomes convex, the face tends to elongate and the jaw is more pronounced. The 
uplifted ear lobes do not change significantly with time and are an excellent diagnostic 
clue (Mowat et al., 2003) (Fig. 3). 
The clinical manifestations of MWS in the about 200 cases described presenting with ZEB2 
mutations have been recently reviewed Garavelli and Cerruti-Mainardi, 2007. In brief, the 
distinct facial phenotype is present in 97% of the patients, at least moderate but usually 
severe mental retardation in all the cases, microcephaly is present in 81%, epilepsy in 73%, 
HSCR in 57%, constipation in 26%, and congenital heart disease (principally, patent ductus 
arteriosus, pulmonary stenosis, ventricular and atrial septal defects, pulmonary artery sling, 
Tetralogy of Fallot and aortic coarctation), in 52% of the cases; urogenital/renal anomalies 
were demonstrated in 51 % of the patients (of which 51% presented hypospadias, 36% 
cryptorchidism and 12.8 % several renal defects). Oropharyngeal and gastrointestinal 
malformations include pyloric stenosis, arched palate, among others. Musculoskeletal 
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anomalies occur in many patients and eye defects have also been demonstrated (4.1% of the 
published cases). Microcephaly is a common feature and is present in 81% of the published 
cases. Brain anomalies reported so far include hypoplasia or agenesis of corpus callosum, 
present in 43% of the published cases, cortical atrophy (Garavelli et al., 2003), pachygyria 
and cerebellar hypoplasia (Silengo et al., 2004), hippocampal formation hypoplasia 
(Kääriäinen et al., 2001) and frontotemporal hypoplasia with temporal dysplasia (Cacheux et 
al., 2001, Mowat et al., 2003). These findings may be under-represented because not all 
published cases employed brain imaging 
 
  
(a)                                                                                  (b) 
Fig. 1. Clinical facial features in MWS: a) In the neonate, excess nuchal skin and scarce fine 
hair can be observed together with high forehead, prominent frontal bone, large wide 
eyebrows, but thinning in the middle part, hypertelorism, strabismus, epicanthus, large 
hollow eyes that originate prominent cheek bones, wide nasal bridge and open mouth, with 
M-shaped upper lip b) Some years later: saddle nose, prominent rounded nasal tip. The 
large and uplifted ear lobes with a central depression do not change significantly with age. 
Regarding differential diagnosis, the facial phenotype of patients with MWS is very 
characteristic. However, due to the frequent presence of HSCR, epilepsy and mental 
retardation it may initially be mistaken as GOSHS, as we previously mentioned in section 
4. The patients with GOSHS share clinical features such as HSCR, epilepsy and mental 
retardation, but have different facial features (high nasal bridge, synophrys, long curled 
eyelashes, palpebral ptosis, and cleft palate). The differential diagnosis can be carried out 
on the basis of facial phenotype and confirmed by mutational analysis of the ZEB2 gene. 
This is important for genetic counseling, since GOSHS is autosomal recessive, whereas 
MWS is a sporadic condition. Since individuals with MWS often show an ataxic-like gait 
and a smiling, sociable personality, combined with absent speech, microcephaly and 
seizures, they can be given a presumptive diagnosis of Angelman syndrome (Williams et 
al., 2001).  
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(a) 
 
(b) 
Fig. 2. Clinical facial features in MWS: 10 years old. Dysmorphic facial features: wide forehead, 
hypertelorism con antimongoloid palpebral fissure, large dense eyebrows, long eyelashes, 
low-set ears, prominent uplifted ear lobes, saddle nose, thin upper lip, the face becomes long 
and thin, with prognathism, and a long, pointed or "chisel-shaped" chin, smiley face. 
www.intechopen.com
Neurocristopathies: Role of Glial Cells, 
Genetic Basis and Relevance of Brain Imaging for Diagnosis 
 
119 
 
Fig. 3. Clinical facial features in MWS. The ear lobes are very typical. They are large and 
uplifted with a central depression and have been described as being like "orecchiette pasta" 
or like "red blood corpuscles" in shape. They do not change significantly with time (with the 
exception of the central depression, which is less obvious in adults) and are an excellent 
diagnostic clue 
However, the distinct facial features of MWS, in addition to the other typical congenital 
anomalies, should allow distinguishing these two conditions. Differential diagnosis is also 
necessary for MWS patients presenting with hypospadias and mental retardation to avoid 
misdiagnosis as Smith-Lemli-Opitz syndrome, Opitz G/BBB syndrome or X-linked mental 
retardation-alpha thalassemia syndrome. Again, facial phenotype should be the clue for 
correct diagnosis. 
In this context, we have recently diagnosed a patient with MWS with the help of molecular 
genetics and neuroimaging (Carrascosa Romero et al., 2009), which we consider an 
interesting and illustrative case. This patient presented a typical facial phenotype and 
molecular genetics analysis showed a heterozygous deletion mutation in the ZEB2 gene 
never described before in the literature. Parents showed no genetic anomalies. Our MWS 
patient showed some previously described malformations such as patent ductus arteriosus, 
Tetralogy of Fallot, atrial septal defect (small ostium secundum) and presented with HSCR. 
Magnetic resonance imaging (MRI) of the brain (Fig. 4, a and b) revealed agenesis of corpus 
callosum and colpocephaly with an important elevation of the third ventricle, cortical 
dysgenesis showing pachygyria in the left perisylvian region and decreased mielinization at 
the biparietal level. The patient also showed severe mental retardation, happy and smiling 
behavior, developed epilepsy when two years of age and was not able to walk until 4 years 
old. The finding of CNS demyelinization, detected with neuroimaging, is of special interest. 
This decrease in oligodendroglia maybe meaningful in the context of neurocristopathies 
given the role of these cells in nervous system maturation, particularly in the regulation of 
ventral neuroectodermal progenitor cell fate (Jakovcevski et al., 2009; Pucharcós et al., 1999) 
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(b) 
Fig. 4. a and b. Magnetic resonance imaging (MRI) of our MWS patient brain. Image analysis 
revealed agenesis of corpus callosum and colpocephaly with an important elevation of the 
third ventricle, cortical dysgenesis showing pachygyria in the left perisylvian region and 
decreased mielinization at the biparietal level. 
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5.1 The ZEB2 gene: Expression and role in neurocristopathies 
As mentioned above, at least 100 mutations have been described for the ZEB2 gene (Dastot-
Le Moal et al., 2007) connected with MWS -including the mutation found for our patient 
(Carrascosa Romero et al., 2009)- which reveals the importance of this gene for the 
development of this disease. 
The ZEB2 gene is 70 Kb long consists of 10 exons and 9 introns and encodes SIP1 (Smad 
interacting protein 1). Although its mechanisms of action on morphogenesis and 
neurogenesis still remain to be clarified, its clinical implications suggest that ZEB2 is 
involved in the development of the cells from the NC (ENS, craniofacial mesoectoderm), 
CNS, and cardiac septation, as well as in the development of the median line (agenesis of 
corpus callosum, urogenital/renal anomalies, pyloric stenosis)(Zweier et al., 2002; Ishihara 
et al., 2004). 
Using mass spectrometry, Verstappen et al. 2008, found that ZEB2 associated with 
multiple subunits of the NURD complex, which plays a key role in transcriptional 
repression. Mi2-beta (CHD4; 603277) was identified as a specific cofactor for ZEB2-
mediated repression of E-cadherin (CDH1; 192090). The N-terminal 289 amino acids of 
ZEB2 were sufficient for interaction with NURD complex subunits. In vitro studies in 
Xenopus oocytes showed broad Zeb2 expression at the gastrula stage, with stronger 
expression in neural tissues and neural crest cells at the neurula stage, suggesting a role in 
neural development. Endogenous Mi2-beta expression broadly overlapped Zeb2 
expression, and antisense morpholino knockdown of Mi2-beta resulted in reduced Zeb2-
mediated repression of Bmp4 (112262) and decreased induction of neural marker Ncam 
(116930). Further studies showed that a mutant ZEB2 protein (605802.0014), differing in 
the first 24 amino acids from the wildtype protein and causing a mild form of Mowat-
Wilson syndrome (235730), was unable to interact with the NURD complex and showed 
decreased transcriptional repression of Bmp4. 
To investigate the breadth of clinical variation associated with mutations in ZFHX1B, 
Yamada et al. 2001, studied DNA samples from 6 patients with clinical features similar to 
those described for ZFHX1B deficiency, except that they did not have Hirschsprung disease. 
The results showed the R695X mutation (605802.0002) to be present in 3 cases, with 3 novel 
mutations being identified in the other 3 patients. All mutations occurred in 1 allele and 
were de novo events. The results demonstrated that ZFHX1B deficiency is an autosomal 
dominant complex developmental disorder and that individuals with functional null 
mutations present with mental retardation, delayed motor development, epilepsy, and a 
wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at the 
cephalic, cardiac, and vagal levels. 
To clarify the molecular mechanisms underlying the clinical features of Hirschsprung 
disease-mental retardation syndrome, Van de Putte et al. 2003 generated mice that carried a 
Zfhx1b mutation comparable to those found in several human patients. They showed that 
Zfhx1b knockout mice did not develop postotic vagal neural crest cells, the precursors of the 
enteric nervous system that is affected in patients with Hirschsprung disease, and displayed 
a delamination arrest of cranial neural crest cells, which form the skeletomuscular elements 
of the vertebral head. This suggests that the gene product is essential for the development of 
vagal neural crest precursors and the migratory behavior of cranial neural crest in the 
mouse. Furthermore, they showed that the gene product was involved in the specification of 
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neuroepithelium. SIP1-knockout embryos died around embryonic day 9.5, with failed 
neural tube closure, lack of a sharp boundary between the neural plate and the rest of the 
ectoderm, and lack of the first branchial arch. It was found that conditional deletion of Zeb2 
in mouse neural crest precursors was lethal at embryonic stages. Mutant mice displayed 
craniofacial and gastrointestinal malformations similar to those of patients with Mowat-
Wilson syndrome. In addition, mutant mice had defects in the heart, melanoblasts, and 
sympathetic and parasympathetic anlagen (Van de Putte et al., 2007). 
A single layer of neuroepithelial cells lining the embryonic neural tube gives rise to the 
entire repertoire of neurons, astrocytes, and oligodendrocytes in the adult central nervous 
system. Seuntjens et al. 2009, found that conditional SIP1 deletion in young mouse neurons 
induced premature production of upper layer neurons at the expense of deep layers, 
precocious and increased generation of glial precursors, and elevated numbers of astrocytes 
at early postnatal stages. Microarray analysis showed that Ntf3 (162660) and Fgf9 (600921) 
were over- and prematurely expressed in mutant brains. In the absence of SIP1, there was 
also a premature peak of MAPK (176948) signalling in neural progenitor cells. It was 
concluded that SIP1 functions in the postmitotic compartment of the neocortex to control the 
expression of growth factor genes that feed back to progenitor cells to regulate production 
of the neurons and glial cells required for corticogenesis.  
6. Conclusion: Relevance of brain imaging and genetics in the diagnosis of 
neurocristopathies 
The association of HSCR (either isolated or within the context of a specific malformation 
syndrome) with neuronal migration anomalies is so strong (23.5%), that we recommend 
performing a full evaluation of HSCR patients including: a) specialized molecular genetic 
studies, b) a complete neurological exploration for all patients diagnosed with HSCR and c) 
neurologist-monitored brain imaging studies in search for cerebral dysgenesis. Conversely, 
when confronting cases of children presenting with mental retardation, dysmorphic features 
and severe constipation, anorectal manometry seems advisable to rule out HSCR. 
The development of neuroimaging techniques is now making possible the detailed 
identification of cerebral dysgenesis compatible with neuronal migration impairments that 
are at the root of a wide range of brain diseases including epilepsy and mental retardation. 
The application of neuroimaging techniques in combination with molecular genetics to 
patients diagnosed with neurocristopathies has an extraordinary potential to connect 
genotype to phenotype and discover possible brain malformations associated with the 
mutations causing these syndromes. 
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